Vera Therapeutics, Inc. (VERA) NASDAQ
40.27
+0.21(+0.52%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
40.27
+0.21(+0.52%)
Currency In USD
| Market Cap | 3.25B |
| Enterprise Value | 2.98B |
| P/E Ratio | -8.63 |
| PEG Ratio | 0.2 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.28 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -9.05 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.41 |
| Return On Equity | -0.6 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -468,000 |
| EBITDA | -291.62M |
| Net Income | -299.62M |
| Diluted EPS | -4.66 |
| Total Cash | 714.59M |
| Total Cash/Share | 11.12 |
| Total Debt | 77.31M |
| Total Debt/Equity | 0.13 |
| Current Ratio | 13.64 |
| Book Value Per Share | 9.41 |
| 52-Week Change | 80.26 |
| 52-Week High | 56.05 |
| 52-Week Low | 18.76 |
| Moving Average 50 Days | 41.1 |
| Moving Average 200 Days | 34.57 |
| Average Volume | 1.17M |
| Shares Outstanding | 71.36M |
| % Held by Institutions | 115.91 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |